Loading...
OTCM
MGROF
Market cap15mUSD
Jul 09, Last price  
0.27USD
1D
9.85%
1Q
-36.30%
IPO
17.39%
Name

MUSTGROW BIOLOGICS CORP.

Chart & Performance

D1W1MN
OTCM:MGROF chart
P/E
P/S
2.64
EPS
Div Yield, %
Shrs. gr., 5y
7.82%
Rev. gr., 5y
372.54%
Revenues
8m
+1,980.25%
12,417109,0152,1022,0000012,8696,4794,712,000398,0188,279,787
Net income
-7m
L+48.33%
-583,000-20,443-197,564-1,893,000-1,518,000-3,310,000-3,064,000-5,566,000-677,000-4,889,000-7,251,750
CFO
-5m
L+41.26%
-580,566-2,567-6,740-968,347-1,352,513-2,578,823-2,411,779-3,257,538-294,764-3,578,296-5,054,644

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MustGrow Biologics Corp., an agricultural biotechnology company headquartered in Saskatoon, Canada, since its incorporation in 2014 (and known as Duport Capital Ltd. until March 2018), specializes in developing and commercializing natural pest and weed control solutions derived from mustard seed. The company provides preplant soil biofumigation technology designed to manage soil-borne diseases and pests across various crops, including fruits and vegetables. Furthermore, MustGrow is actively developing bioherbicides to control undesirable plant growth, targeting applications in organic and conventional agriculture, as well as the home and garden sectors. Its work also extends to postharvest food preservation, focusing on treatments to prevent sprouting, disease, and pathogens during storage. Among its key innovations is CannaPM, an active ingredient being developed to address both fungal soil diseases and foliar diseases.
IPO date
Jul 10, 2019
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT